| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6009424 | Clinical Neurophysiology | 2009 | 4 Pages |
Abstract
Future neuroprotective therapies of polyglutamine neurodegeneration may be assessed by MSV from earliest to prefinal disease stages.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
L. Velázquez-Pérez, C. Seifried, M. Abele, F. Wirjatijasa, R. RodrÃguez-Labrada, N. Santos-Falcón, G. Sánchez-Cruz, L. Almaguer-Mederos, R. Tejeda, N. Canales-Ochoa, M. Fetter, U. Ziemann, T. Klockgether, J. Medrano-Montero, J. RodrÃguez-DÃaz,